The 11 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 46.00, with a high estimate of 60.00 and a low estimate of 33.00. The median estimate represents a +231.65% increase from the last price of 13.87.
The current consensus among 13 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.37
Reporting Date Feb 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.